Skip to main content

Table 1 Site-specific burden of cancer (YLLs, YLDs, DALYs) per 100,000 by sex in 2016

From: Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program

ICD-10

Cancer site

YLLs-ASR

YLDs-ASR

DALYs-ASR

% YLLs to DALYs

Males

Females

Total

Males

Females

Total

Males

Females

Total

C00

Lip

3.5

1.7

2.6

0.5

0.2

0.3

3.9

1.9

2.9

88.3

C01-C02

Tongue

61.4

20.8

41.1

5.7

2.0

3.9

67.2

22.8

45.0

91.4

C03-C06

Mouth

81.6

34.1

57.8

8.0

3.4

5.7

89.6

37.4

63.5

91.0

C07-C08

Salivary Gland

3.7

2.0

2.9

0.8

0.7

0.8

4.5

2.7

3.6

79.0

C09

Tonsil

11.8

2.1

6.9

1.1

0.3

0.7

13.0

2.3

7.7

90.7

C10

Other Oropharynx

12.4

2.1

7.2

0.9

0.2

0.6

13.3

2.3

7.8

92.6

C11

Nasopharynx

7.9

3.3

5.6

0.7

0.4

0.5

8.6

3.6

6.1

91.7

C12-C13

Hypopharynx

29.8

7.9

18.8

2.7

0.6

1.7

32.5

8.5

20.5

91.9

C14

Pharynx Unspecified

11.3

3.5

7.4

0.5

0.2

0.3

11.8

3.6

7.7

95.5

C15

Oesophagus

84.3

44.3

64.3

5.1

3.1

4.1

89.4

47.4

68.4

94.0

C16

Stomach

72.3

41.9

57.1

4.4

2.4

3.4

76.7

44.3

60.5

94.4

C17

Small Intestine

3.6

2.6

3.1

0.3

0.2

0.3

3.9

2.9

3.4

91.9

C18

Colon

31.1

25.6

28.4

2.9

2.2

2.5

34.0

27.8

30.9

91.8

C19-C20

Rectum

29.8

21.4

25.6

2.8

1.9

2.4

32.6

23.4

28.0

91.6

C21

Anus and Anal cavity

3.9

2.9

3.4

0.5

0.3

0.4

4.3

3.2

3.8

89.3

C22

Liver

71.5

32.6

52.1

3.4

1.5

2.4

74.9

34.1

54.5

95.6

C23-C24

Gallbladder

29.4

54.7

42.1

2.1

3.6

2.8

31.5

58.3

44.9

93.7

C25

Pancreas

29.4

20.6

25.0

1.6

1.1

1.3

31.0

21.7

26.4

95.0

C30-C31

Nose, Sinuses

4.0

1.9

3.0

0.5

0.4

0.4

4.4

2.3

3.4

87.7

C32

Larynx

38.8

5.6

22.2

4.2

0.6

2.4

43.0

6.2

24.6

90.2

C33-C34

Lung

173.5

70.3

121.9

9.8

3.8

6.8

183.3

74.1

128.7

94.7

C37-C38

Other Thoracic Organs

4.0

2.7

3.3

0.3

0.2

0.2

4.2

2.8

3.5

93.7

C40-C41

Bone

13.8

10.2

12.0

1.1

0.8

1.0

14.9

11.0

12.9

92.6

C43

Melanoma of Skin

2.3

1.7

2.0

0.5

0.5

0.5

2.8

2.2

2.5

80.9

C44

Other Skin

9.1

6.9

8.0

1.3

1.3

1.3

10.5

8.2

9.3

86.0

C45

Mesothelioma

0.2

0.1

0.2

0.1

0.1

0.1

0.3

0.2

0.2

63.6

C46

Kaposi Sarcoma

0.2

0.3

0.2

0.0

0.2

0.1

0.2

0.5

0.3

62.0

C47 + C49

Connective & Soft Tissue

8.8

7.3

8.0

1.1

1.0

1.1

10.0

8.2

9.1

88.4

C50

Breast

5.7

203.6

104.6

0.8

29.1

15.0

6.5

232.7

119.6

87.5

C51

Vulva

0.0

2.4

1.2

0.0

0.4

0.2

0.0

2.8

1.4

85.0

C52

Vagina

0.0

3.2

1.6

0.0

0.5

0.3

0.0

3.7

1.9

86.2

C53

Cervix Uteri

0.0

87.6

43.8

0.0

11.0

5.5

0.0

98.6

49.3

88.9

C54

Corpus Uteri

0.0

14.9

7.5

0.0

3.9

1.9

0.0

18.8

9.4

79.4

C55

Uterus Unspecified

0.0

7.8

3.9

0.0

0.6

0.3

0.0

8.4

4.2

93.4

C56

Ovary

0.0

72.9

36.5

0.0

5.9

3.0

0.0

78.9

39.4

92.5

C57

Other Female Genital organs

0.0

0.6

0.3

0.0

0.1

0.1

0.0

0.7

0.4

84.1

C58

Placenta

0.0

0.3

0.2

0.0

0.7

0.4

0.0

1.1

0.5

31.0

C60

Penis

5.5

0.0

2.7

0.9

0.0

0.4

6.4

0.0

3.2

86.0

C61

Prostate

40.3

0.0

20.2

6.5

0.0

3.3

46.9

0.0

23.4

86.0

C62

Testis

4.5

0.0

2.3

0.6

0.0

0.3

5.1

0.0

2.6

88.7

C63

Other Male Genital organs

0.4

0.0

0.2

0.2

0.0

0.1

0.6

0.0

0.3

66.5

C64

Kidney

16.6

7.3

12.0

1.8

0.8

1.3

18.4

8.1

13.3

90.1

C65

Renal Pelvis

0.2

0.1

0.1

0.1

0.2

0.1

0.3

0.3

0.3

50.8

C66

Ureter

0.2

0.1

0.2

0.1

0.1

0.1

0.3

0.2

0.3

63.0

C67

Bladder

21.3

6.0

13.6

3.5

0.9

2.2

24.8

6.9

15.8

86.1

C68

Unspecified Urinary Organs

0.7

0.2

0.5

0.1

0.1

0.1

0.8

0.3

0.6

84.4

C69

Eye

1.5

0.8

1.2

0.4

0.5

0.4

1.9

1.3

1.6

72.8

C70-C72

Brain, Nervous System

37.7

26.1

31.9

2.2

1.5

1.9

39.9

27.6

33.7

94.5

C73

Thyroid

5.2

9.3

7.2

4.1

3.7

3.9

9.3

13.0

11.1

65.1

C74

Adrenal Gland

1.2

1.0

1.1

0.4

0.2

0.3

1.7

1.2

1.4

77.6

C81

Hodgkin’s Disease

7.5

4.5

6.0

1.0

0.6

0.8

8.5

5.1

6.8

88.6

C82-C85

Non-Hodgkin's Lymphoma

38.9

24.1

31.5

2.9

1.9

2.4

41.8

26.0

33.9

92.9

C88

Malignant Immunoproliferative Diseases

0.3

0.3

0.3

0.04

0.00

0.0

0.3

0.3

0.3

93.7

C90

Multiple Myeloma

15.5

12.8

14.1

1.4

1.1

1.2

16.9

13.8

15.4

92.0

C91

Lymphoid Leukaemia.

30.8

20.7

25.7

1.8

0.9

1.3

32.5

21.6

27.1

95.0

C92-C94

Myeloid Leukaemia

38.8

31.6

35.2

1.8

1.3

1.5

40.6

32.9

36.7

95.9

C95

Leukaemia Unspecified

14.7

10.8

12.8

0.4

0.4

0.4

15.1

11.2

13.2

97.0

C96

CMD, O&U LHM

1.3

0.8

1.0

0.1

0.1

0.1

1.4

0.9

1.1

91.3

O&Ua

Other and unspecified

141.6

113.6

127.6

6.0

4.3

5.1

147.6

117.8

132.7

96.1

All cancer sites

1268.5

1097.4

1183.0

91.8

98.3

95.1

1360.39

1195.8

1278.1

92.6

  1. aO&U includes the Sites (ICD-10:C26, C39, C48, C75, C76, C77, C78, C79, C80, C97)
  2. CMD Chronic Myeloproliferative Disease, O&U LHM Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue